BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 12035397)

  • 1. Drugs used in heart disease. 2. Pharmacology.
    Shulman R; Davies R; Landowski R
    Nurs Times; 2002 May 7-13; 98(19):41-4. PubMed ID: 12035397
    [No Abstract]   [Full Text] [Related]  

  • 2. [Medical treatment of atherosclerosis].
    Schmermund A; Wieneke H; Erbel R
    Med Monatsschr Pharm; 2005 Sep; 28(9):300-8. PubMed ID: 16163880
    [No Abstract]   [Full Text] [Related]  

  • 3. Gender, ethnicity, and genes in cardiovascular disease. Part 2: implications for pharmacotherapy.
    Schaefer BM; Caracciolo V; Frishman WH; Charney P
    Heart Dis; 2003; 5(3):202-14. PubMed ID: 12783634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systolic heart failure: a prothrombotic state.
    de Peuter OR; Kok WE; Torp-Pedersen C; Büller HR; Kamphuisen PW
    Semin Thromb Hemost; 2009 Jul; 35(5):497-504. PubMed ID: 19739040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Sex differences and cardiovascular drugs].
    Løchen ML; Kvan E
    Tidsskr Nor Laegeforen; 2010 Feb; 130(4):382-4. PubMed ID: 20220863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular drug therapy in the elderly.
    Aronow WS; Frishman WH; Cheng-Lai A
    Cardiol Rev; 2007; 15(4):195-215. PubMed ID: 17575484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Thrombocyte aggregation inhibitors, anticoagulants and thrombolytic agents in heart diseases].
    Darius H; Erbel R; Belz GG; Meyer J
    Internist (Berl); 1992 Oct; 33(10):670-83. PubMed ID: 1428685
    [No Abstract]   [Full Text] [Related]  

  • 8. Cardiovascular protection paradigms: is change on the horizon?
    Papademetriou V
    Rev Cardiovasc Med; 2007; 8(4):200-13. PubMed ID: 18192943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Drugs used in cardiovascular diseases and cytokines].
    Andrzejczak D; Górska D
    Wiad Lek; 2006; 59(3-4):232-7. PubMed ID: 16813270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heart-protective drugs: a primer. Back to basics on how they work, side effects, interactions.
    Heart Advis; 2004 Dec; 7(12):3. PubMed ID: 15779133
    [No Abstract]   [Full Text] [Related]  

  • 11. Herbs of activating blood circulation to remove blood stasis.
    Liao F
    Clin Hemorheol Microcirc; 2000; 23(2-4):127-31. PubMed ID: 11321431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardioembolic stroke: call for a multidisciplinary approach.
    Babarro EG; Rego AR; González-Juanatey JR
    Cerebrovasc Dis; 2009; 27 Suppl 1():82-7. PubMed ID: 19342836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of use of cardiovascular drugs in 499 patients with suspected coronary artery disease at time of hospitalization for coronary angiography and in 357 patients with obstructive coronary artery disease documented by coronary angiography.
    Mazar M; Schair B; Aronow WS; Khalique O; Lehrman SG
    Am J Ther; 2008; 15(5):458-60. PubMed ID: 18806522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of calcium channel blockers and angiotensin-converting enzyme inhibitors after cardiac transplantation.
    Rockx MA; Haddad H
    Curr Opin Cardiol; 2007 Mar; 22(2):128-32. PubMed ID: 17284992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of basic therapy of ischemic heart disease on vascular-platelet hemostasis during myocardial revascularization].
    Vorob'eva NA; Nedashkovskiĭ EV
    Anesteziol Reanimatol; 2001; (3):47-50. PubMed ID: 11510359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Progress in cardiovascular pharmacology].
    Zhu JR
    Zhonghua Xin Xue Guan Bing Za Zhi; 1993 Dec; 21(6):358-60. PubMed ID: 7913889
    [No Abstract]   [Full Text] [Related]  

  • 17. Update on pharmacology of antiplatelets, anticoagulants, and thrombolytics.
    Cheng-Ching E; Samaniego EA; Naravetla BR; Zaidat OO; Hussain MS
    Neurology; 2012 Sep; 79(13 Suppl 1):S68-76. PubMed ID: 23008416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antithrombotic drugs.
    Treat Guidel Med Lett; 2011 Oct; 9(110):61-6; quiz 2 p following 66. PubMed ID: 21941228
    [No Abstract]   [Full Text] [Related]  

  • 19. Angiotensin II receptor blockers: current perspective.
    Agrawal V; Manohar G; Kasliwal RR
    J Assoc Physicians India; 2003 Jul; 51():706-13. PubMed ID: 14621043
    [No Abstract]   [Full Text] [Related]  

  • 20. Cardiovascular drugs in pregnancy.
    Frishman WH; Elkayam U; Aronow WS
    Cardiol Clin; 2012 Aug; 30(3):463-91. PubMed ID: 22813371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.